Literature DB >> 9892466

Supercritical fluid processing of materials from aqueous solutions: the application of SEDS to lactose as a model substance.

S Palakodaty1, P York, J Pritchard.   

Abstract

PURPOSE: The objective of the work was to study the factors influencing the crystallisation of alpha-lactose monohydrate from aqueous solution using the Solution Enhanced Dispersion by Supercritical Fluids (SEDS) technique.
METHODS: An aqueous solution of alpha-lactose monohydrate is dispersed with a homogeneous mixture of carbon dioxide-ethanol/methanol using a co-axial nozzle. Crystallised lactose particles were analysed for water content by Karl-Fisher analysis, anomeric composition by Differential Scanning Calorimetry (DSC) and characterised for crystallinity by powder X-ray diffraction and morphology by scanning electron microscopy.
RESULTS: Water content in the lactose recrystallised with ethanol was higher compared to the product obtained with methanol as cosolvent. Rate of crystallisation could be altered by varying the CO2 flow thereby modifying the water content in the lactose. At low flow rates of CO2, the crystallisation occurred in a cosolvent rich antisolvent phase causing rapid crystallisation whereas high flow rates of CO2 favoured a much slower crystallisation mechanism in the water rich phase. As a consequence, the morphology changed from thin long bands to large agglomerated chunks with mean particle size between 5 and 31 microns.
CONCLUSIONS: The SEDS process is an efficient method for forming micron sized particles of water-soluble compounds with controlled physico-chemical properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9892466     DOI: 10.1023/a:1011949805156

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  1 in total

1.  Formation of microparticulate protein powder using a supercritical fluid antisolvent.

Authors:  S D Yeo; G B Lim; P G Debendetti; H Bernstein
Journal:  Biotechnol Bioeng       Date:  1993-02-05       Impact factor: 4.530

  1 in total
  8 in total

Review 1.  Phase behavioral effects on particle formation processes using supercritical fluids.

Authors:  S Palakodaty; P York
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system.

Authors:  Rana T Bustami; Hak-Kim Chan; Theresa Sweeney; Fariba Dehghani; Neil R Foster
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

3.  Polymorph control of sulfathiazole in supercritical CO2.

Authors:  A Kordikowski; T Shekunov; P York
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

Review 4.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

5.  Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.

Authors:  Todd M Martin; Nagesh Bandi; Ryan Shulz; Christopher B Roberts; Uday B Kompella
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

Review 6.  Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications.

Authors:  Ranjith Kumar Kankala; Yu Shrike Zhang; Shi-Bin Wang; Chia-Hung Lee; Ai-Zheng Chen
Journal:  Adv Healthc Mater       Date:  2017-07-28       Impact factor: 9.933

Review 7.  Solution-enhanced dispersion by supercritical fluids: an ecofriendly nanonization approach for processing biomaterials and pharmaceutical compounds.

Authors:  Ranjith Kumar Kankala; Biao-Qi Chen; Chen-Guang Liu; Han-Xiao Tang; Shi-Bin Wang; Ai-Zheng Chen
Journal:  Int J Nanomedicine       Date:  2018-07-23

Review 8.  Solid Dosage Forms of Biopharmaceuticals in Drug Delivery Systems Using Sustainable Strategies.

Authors:  Clarinda Costa; Teresa Casimiro; Maria Luísa Corvo; Ana Aguiar-Ricardo
Journal:  Molecules       Date:  2021-12-17       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.